pharma-话题@MedSci

#pharma#

608篇内容 | 2474人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1908708, encodeId=c4a01908e082c, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：栀子豉汤通过调节GSH/GSSG途径减轻氧化应激损伤逆转CUMS大鼠抑郁行为, objectType=article, longId=728082, objectId=629ee28082cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=629ee28082cf, replyNumber=0, likeNumber=73, createdTime=2022-06-18, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=629ee28082cf, moduleTitle=Front Pharmacol：栀子豉汤通过调节GSH/GSSG途径减轻氧化应激损伤逆转CUMS大鼠抑郁行为, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=629ee28082cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908671, encodeId=9a7819086e143, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Rhizen Pharmaceuticals AG宣布，在一项有关使用其新型PARP抑制剂(RP12146)治疗晚期实体瘤的I/Ib期研究中进行了首例患者给药, objectType=article, longId=219842, objectId=267d219842d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=267d219842d5, replyNumber=0, likeNumber=79, createdTime=2022-01-07, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=267d219842d5, moduleTitle=Rhizen Pharmaceuticals AG宣布，在一项有关使用其新型PARP抑制剂(RP12146)治疗晚期实体瘤的I/Ib期研究中进行了首例患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=267d219842d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908672, encodeId=48ad19086e290, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：microRNA在肺栓塞中的作用, objectType=article, longId=219945, objectId=d7e2219945a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7e2219945a9, replyNumber=0, likeNumber=63, createdTime=2022-01-14, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7e2219945a9, moduleTitle=Front Pharmacol：microRNA在肺栓塞中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7e2219945a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908664, encodeId=06a41908664f2, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=武田与JCR Pharmaceuticals合作，将亨特综合征下一代治疗药物商业化, objectType=article, longId=218421, objectId=20732184217a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20732184217a, replyNumber=0, likeNumber=97, createdTime=2022-05-18, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20732184217a, moduleTitle=武田与JCR Pharmaceuticals合作，将亨特综合征下一代治疗药物商业化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20732184217a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908720, encodeId=b4081908e20cf, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacol Res：中医药在脑出血病理生理过程中的应用, objectType=article, longId=730952, objectId=5393e309525d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5393e309525d, replyNumber=0, likeNumber=76, createdTime=2023-02-09, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5393e309525d, moduleTitle=Pharmacol Res：中医药在脑出血病理生理过程中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5393e309525d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908699, encodeId=32ee19086999a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：中药复方丹参白疕消对咪喹莫特所致小鼠银屑病样炎症的改善作用, objectType=article, longId=724774, objectId=134fe2477417, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=134fe2477417, replyNumber=0, likeNumber=65, createdTime=2022-12-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=134fe2477417, moduleTitle=Front Pharmacol：中药复方丹参白疕消对咪喹莫特所致小鼠银屑病样炎症的改善作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=134fe2477417)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908670, encodeId=fc8319086e00b, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Clin Pharmacol Ther：有针对性地利用安慰剂效应可有效减少特应性皮炎患者的瘙痒 , objectType=article, longId=219699, objectId=f15921969996, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f15921969996, replyNumber=0, likeNumber=62, createdTime=2022-08-10, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f15921969996, moduleTitle=Clin Pharmacol Ther：有针对性地利用安慰剂效应可有效减少特应性皮炎患者的瘙痒 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f15921969996)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908686, encodeId=22f019086861f, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Eur Rev Med Pharmacol Sci：在意大利COVID-19大流行封锁期间，艾多沙班治疗狼疮抗凝物阳性患者静脉血栓栓塞/肺栓塞的真实世界研究, objectType=article, longId=299655, objectId=33a02996554c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33a02996554c, replyNumber=0, likeNumber=63, createdTime=2022-07-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33a02996554c, moduleTitle=Eur Rev Med Pharmacol Sci：在意大利COVID-19大流行封锁期间，艾多沙班治疗狼疮抗凝物阳性患者静脉血栓栓塞/肺栓塞的真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33a02996554c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908655, encodeId=e4571908655a0, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=British journal of clinical pharmacology：STEMI溶栓·大家谈｜王智勇：肝素化是溶栓时进行还是溶栓后进行？哪种方案更好？, objectType=article, longId=217506, objectId=e18d21e50675, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e18d21e50675, replyNumber=0, likeNumber=89, createdTime=2021-10-17, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e18d21e50675, moduleTitle=British journal of clinical pharmacology：STEMI溶栓·大家谈｜王智勇：肝素化是溶栓时进行还是溶栓后进行？哪种方案更好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e18d21e50675)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908710, encodeId=b0881908e109c, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=J Ethnopharmacol：归黄方治疗慢性前列腺炎的多靶点作用机制研究, objectType=article, longId=728086, objectId=c3d8e2808626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3d8e2808626, replyNumber=0, likeNumber=74, createdTime=2023-05-03, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3d8e2808626, moduleTitle=J Ethnopharmacol：归黄方治疗慢性前列腺炎的多靶点作用机制研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3d8e2808626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908678, encodeId=51d419086e897, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Liverpool CCG和Community Pharmacy Liverpool在100多家社区药房推出FebriDx®服务, objectType=article, longId=294033, objectId=9a9f29403370, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a9f29403370, replyNumber=0, likeNumber=46, createdTime=2022-12-16, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a9f29403370, moduleTitle=Liverpool CCG和Community Pharmacy Liverpool在100多家社区药房推出FebriDx®服务, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a9f29403370)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908681, encodeId=22e01908681bf, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Pharmacol Res：GIP和GLP-2共同改善支持GIPR-GLP-2R共激动剂作为未来骨质疏松症治疗的人类骨转换, objectType=article, longId=294731, objectId=07dc294e315d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07dc294e315d, replyNumber=0, likeNumber=64, createdTime=2022-11-27, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07dc294e315d, moduleTitle=Pharmacol Res：GIP和GLP-2共同改善支持GIPR-GLP-2R共激动剂作为未来骨质疏松症治疗的人类骨转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07dc294e315d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908674, encodeId=10d419086e488, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Front Pharmacol：评估慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停综合征重叠综合征患者的长期预后, objectType=article, longId=220319, objectId=a421220319f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a421220319f1, replyNumber=0, likeNumber=87, createdTime=2022-04-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a421220319f1, moduleTitle=Front Pharmacol：评估慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停综合征重叠综合征患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a421220319f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908636, encodeId=861e19086361a, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Prog Neuropsychopharmacol Biol Psychiatry：伴有胃肠道症状的重度抑郁症患者的脑结构发生改变, objectType=article, longId=213276, objectId=5eb32132e607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5eb32132e607, replyNumber=0, likeNumber=74, createdTime=2022-02-02, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5eb32132e607, moduleTitle=Prog Neuropsychopharmacol Biol Psychiatry：伴有胃肠道症状的重度抑郁症患者的脑结构发生改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5eb32132e607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908687, encodeId=b9ad190868ec4, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=J Ethnopharmacol：中成药艾迪注射液治疗癌症的系统评价和荟萃分析, objectType=article, longId=301052, objectId=c31830105236, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c31830105236, replyNumber=0, likeNumber=130, createdTime=2022-11-07, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c31830105236, moduleTitle=J Ethnopharmacol：中成药艾迪注射液治疗癌症的系统评价和荟萃分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c31830105236)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908667, encodeId=f3c5190866eb9, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=J Ethnopharmacol：参芪降糖颗粒拮抗胰岛素抵抗的药理机制, objectType=article, longId=219300, objectId=55292193001d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55292193001d, replyNumber=0, likeNumber=70, createdTime=2022-01-04, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55292193001d, moduleTitle=J Ethnopharmacol：参芪降糖颗粒拮抗胰岛素抵抗的药理机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55292193001d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908682, encodeId=564f19086820d, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Alvotech与BiosanaPharma达成全球独家许可协议，共同开发Xolair®（奥马珠单抗）的拟议生物仿制药(AVT23), objectType=article, longId=295364, objectId=dce229536434, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dce229536434, replyNumber=0, likeNumber=67, createdTime=2022-08-01, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dce229536434, moduleTitle=Alvotech与BiosanaPharma达成全球独家许可协议，共同开发Xolair®（奥马珠单抗）的拟议生物仿制药(AVT23), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dce229536434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908637, encodeId=4c54190863e8b, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Neuropsychopharmacology：结构连接体的测量可能有助于预测青年双相情感障碍的药物治疗结果, objectType=article, longId=213272, objectId=65822132e265, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65822132e265, replyNumber=0, likeNumber=65, createdTime=2022-05-25, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65822132e265, moduleTitle=Neuropsychopharmacology：结构连接体的测量可能有助于预测青年双相情感障碍的药物治疗结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65822132e265)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908689, encodeId=2fde1908689f3, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Biomed Pharmacother：中药及天然提取物治疗狼疮性肾炎的进展, objectType=article, longId=301385, objectId=92e13013853f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92e13013853f, replyNumber=0, likeNumber=87, createdTime=2023-02-23, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92e13013853f, moduleTitle=Biomed Pharmacother：中药及天然提取物治疗狼疮性肾炎的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92e13013853f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1908676, encodeId=6b6f19086e69f, content=<a href='/topic/show?id=a8d0141605e' target=_blank style='color:#2F92EE;'>#pharma#</a>, objectTitle=Aliment Pharmacol Ther：血清GDF15可预测丙型肝炎病毒消除后肝癌的发生风险, objectType=article, longId=221186, objectId=d8da22118698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8da22118698, replyNumber=0, likeNumber=101, createdTime=2022-06-29, rootId=0, userName=chentianping, userId=f634250, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8da22118698, moduleTitle=Aliment Pharmacol Ther：血清GDF15可预测丙型肝炎病毒消除后肝癌的发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8da22118698)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

pharma

2020-05-29

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：栀子豉汤通过调节GSH/GSSG途径减轻氧化应激损伤逆转CUMS大鼠抑郁行为

2022-06-18

chentianping (审核中...)

前往app查看评论内容

#pharma#

Rhizen Pharmaceuticals AG宣布，在一项有关使用其新型PARP抑制剂(RP12146)治疗晚期实体瘤的I/Ib期研究中进行了首例患者给药

2022-01-07

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：microRNA在肺栓塞中的作用

2022-01-14

chentianping (审核中...)

前往app查看评论内容

#pharma#

武田与JCR Pharmaceuticals合作，将亨特综合征下一代治疗药物商业化

2022-05-18

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacol Res：中医药在脑出血病理生理过程中的应用

2023-02-09

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：中药复方丹参白疕消对咪喹莫特所致小鼠银屑病样炎症的改善作用

2022-12-10

chentianping (审核中...)

前往app查看评论内容

#pharma#

Clin Pharmacol Ther：有针对性地利用安慰剂效应可有效减少特应性皮炎患者的瘙痒

2022-08-10

chentianping (审核中...)

前往app查看评论内容

#pharma#

Eur Rev Med Pharmacol Sci：在意大利COVID-19大流行封锁期间，艾多沙班治疗狼疮抗凝物阳性患者静脉血栓栓塞/肺栓塞的真实世界研究

2022-07-23

chentianping (审核中...)

前往app查看评论内容

#pharma#

British journal of clinical pharmacology：STEMI溶栓·大家谈｜王智勇：肝素化是溶栓时进行还是溶栓后进行？哪种方案更好？

2021-10-17

chentianping (审核中...)

前往app查看评论内容

#pharma#

J Ethnopharmacol：归黄方治疗慢性前列腺炎的多靶点作用机制研究

2023-05-03

chentianping (审核中...)

前往app查看评论内容

#pharma#

Liverpool CCG和Community Pharmacy Liverpool在100多家社区药房推出FebriDx®服务

2022-12-16

chentianping (审核中...)

前往app查看评论内容

#pharma#

Pharmacol Res：GIP和GLP-2共同改善支持GIPR-GLP-2R共激动剂作为未来骨质疏松症治疗的人类骨转换

2022-11-27

chentianping (审核中...)

前往app查看评论内容

#pharma#

Front Pharmacol：评估慢性阻塞性肺疾病和阻塞性睡眠呼吸暂停综合征重叠综合征患者的长期预后

2022-04-01

chentianping (审核中...)

前往app查看评论内容

#pharma#

Prog Neuropsychopharmacol Biol Psychiatry：伴有胃肠道症状的重度抑郁症患者的脑结构发生改变

2022-02-02

chentianping (审核中...)

前往app查看评论内容

#pharma#

J Ethnopharmacol：中成药艾迪注射液治疗癌症的系统评价和荟萃分析

2022-11-07

chentianping (审核中...)

前往app查看评论内容

#pharma#

J Ethnopharmacol：参芪降糖颗粒拮抗胰岛素抵抗的药理机制

2022-01-04

chentianping (审核中...)

前往app查看评论内容

#pharma#

Alvotech与BiosanaPharma达成全球独家许可协议，共同开发Xolair®（奥马珠单抗）的拟议生物仿制药(AVT23)

2022-08-01

chentianping (审核中...)

前往app查看评论内容

#pharma#

Neuropsychopharmacology：结构连接体的测量可能有助于预测青年双相情感障碍的药物治疗结果

2022-05-25

chentianping (审核中...)

前往app查看评论内容

#pharma#

Biomed Pharmacother：中药及天然提取物治疗狼疮性肾炎的进展

2023-02-23

chentianping (审核中...)

前往app查看评论内容

#pharma#

Aliment Pharmacol Ther：血清GDF15可预测丙型肝炎病毒消除后肝癌的发生风险

2022-06-29

科室
- - 订阅+
  - 更多科室
工具
服务